Loading clinical trials...
Loading clinical trials...
A 12-week, double-blind, placebo-controlled parallel group study will be conducted with 150 outpatients with alcohol dependence, with random assignment to pregabalin 300 mg/d, duloxetine 40 mg/d, or p...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
The Scripps Research Institute
Collaborators
NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more
NCT06265506 · Alcohol Use Disorder, Alcohol Drinking, and more
NCT04014413 · Crohn Disease, Ulcerative Colitis, and more
NCT04164940 · Alcohol Consumption, Alcohol; Harmful Use, and more
NCT06173973 · Alcohol Use Disorder, Alcohol Withdrawal, and more
The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research
La Jolla, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions